Physician profile
Desiree O Garzon
NPI 1750701249
$6,973.38
in general payments reported to CMS, 2019-2025
29 companies · $2,031 in 2025
The $2,031 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $337 · 2021: $432 · 2022: $529 · 2023: $1,107 · 2024: $1,555 · 2025: $2,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,795 · Travel and Lodging: $752 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,795.23 |
| Travel and Lodging | $752.14 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,748.11 | 2022-2025 | |
| Stryker Corporation | $1,269.47 | 2020-2024 | Prostep, Anchorage, Prophecy |
| Integra Lifesciences Corporation | $617.90 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $579.95 | 2019-2025 | Grafix Pl, Stravix, Versajet |
| Organogenesis INC. | $268.53 | 2019-2025 | Puraply Wound Matrix |
| Wright Medical Technology, INC. | $239.17 | 2019-2020 | |
| Djo, LLC | $215.36 | 2019-2023 | Cmf |
| Cardiovascular Systems INC. | $177.64 | 2019-2020 | |
| Medshape, INC. | $151.32 | 2022-2023 | Dynanail Hybrid |
| Amgen INC. | $149.50 | 2025 | Krystexxa |
| Acera Surgical, INC. | $148.64 | 2022 | |
| Abbott Laboratories | $140.67 | 2021 | |
| Depuy Synthes Sales INC. | $130.95 | 2022-2025 | Motoband |
| Paratek Pharmaceuticals, INC. | $124.99 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $122.43 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $116.39 | 2024 | Colink 2, 5ms |
| Trice Medical, INC. | $113.11 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $111.76 | 2022-2025 | Exparel |
| Biocomposites INC | $106.35 | 2025 | Stimulan |
| Cook Medical LLC | $100.25 | 2019 | |
| Kerecis Limited | $93.18 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acell, INC. | $86.00 | 2019 | |
| Orthofix Medical, INC. | $55.62 | 2019-2022 | |
| Grt US Holding, INC. | $23.25 | 2022 | |
| Biotissue Holdings INC. | $21.72 | 2021 | |
| Triad Life Sciences INC. | $19.01 | 2022 | |
| Highridge Medical LLC | $15.10 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $14.68 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Bioventus LLC | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Garzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.